Dysregulation of miR-181c also contributes to the aggressiveness of osteosarcoma and regulation of TGF-β signaling through targeting SMAD family member 7 (SMAD7), which negatively regulates TGF-β (Fu et al., 2019). This evidence concerns the gene SMAD7 and osteosarcoma.